About Dermapharm
Dermapharm is a publicly listed company based in Grunwald (Germany) founded in 1991. Dermatological and pharmaceutical medications are developed and manufactured. The company has 3,600 employees. Dermapharm has completed 10 acquisitions, including AllergoPharma, Arkopharma and Axicorp. Its chief executive, as recorded, is Wilhelm Beier. Dermapharm offers products and services including Vitamin D Supplements and Herpes Treatment Device. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas. Its legal entity is Dermapharm AG.
Company details
Dermapharm was founded in 1991 and is headquartered in Grunwald, Germany. Operations center on the pharmaceutical sector, with development and production of medications for skin conditions, allergies, and related health issues. The product range encompasses topical dermatological treatments and vitamin supplements. Patient support resources and educational materials are offered to assist users. Focus remains on standard healthcare solutions within the industry.
- Headquarters Grunwald, Germany
- Employees 3,600
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website dermapharm.de
- Social LinkedIn
- Legal Name Dermapharm Holding Se
- Annual Revenue$1.36 B (USD)-1.34as on Dec 31, 2025
- Net Profit$155.58 M (USD)16.37as on Dec 31, 2025
- EBITDA$369.31 M (USD)5.51as on Dec 31, 2025
- Employee Count3,600
- Investments & AcquisitionsAllergoPharma
& 9 more
Products & Services of Dermapharm
Dermapharm offers a comprehensive portfolio of products and services, including Vitamin D Supplements and Herpes Treatment Device.
Vitamin D supplements are provided for immune system support and individualized dosing in various health applications.
A herpes treatment device is offered for managing lip herpes through warmth application.
People of Dermapharm
1 people are tracked at Dermapharm (1 in leadership); the tracked headcount is 3,600.
| Name | Role | Group |
|---|---|---|
Wilhelm Beier | CEO | Leadership |
Complete people profiles for Dermapharm
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Dermapharm
Dermapharm is a publicly listed company on the XETR with ticker symbol DMP in Germany, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date09 Feb 2018
- Listed onFRA: DMP
- Listed entityDermapharm Holding SE
- Exchange sectorHealth technology
- ISINDE000A2GS5D8
- Share price38.55 EUR (+1.85% on the day) · 2026-10-14
- Market capitalisation1,875,119,569.00 EUR
- Price to earnings14.0
- EPS (diluted, trailing year)2.76 EUR
- Dividend yield2.32%
- Volume (last session)3,463
Financials of Dermapharm
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 1.16B EUR | 132.4M EUR | 314.3M EUR |
| 2024 | 1.18B EUR | 113.8M EUR | 297.9M EUR |
| 2023 | 1.14B EUR | 62.4M EUR | 304.9M EUR |
| 2022 | 1.02B EUR | 134.2M EUR | 362.1M EUR |
| 2021 | 942.9M EUR | 209.6M EUR | 334.0M EUR |
Detailed financial statements for Dermapharm
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dermapharm
Dermapharm has strategically engaged in corporate development activities, having acquired 10 companies. Notable acquisitions include AllergoPharma, Arkopharma and Axicorp.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Satellite components and launch structures are manufactured for space missions. | arkopharma.com | Carros, France | 1980 | Jan 2023 | $483.59M | |
Cannabis-derived pharmaceutical products are manufactured, researched, and distributed. | c3-company.de | Germany | 0 | Dec 2021 | •••• | |
Allergen immunotherapies for IgE-mediated diseases are developed by AllergoPharma. | allergopharma.com | Reinbek, Germany | 1969 | Feb 2020 | •••• | |
Nutritional products are provided as a private label brand. | fitvia.de | Wiesbaden, Germany | 2015 | Jun 2019 | •••• | |
Manufacturer of standardized herbal extracts and botanical active ingredients | euromedgroup.com | 0 | Jan 2019 | •••• | ||
Limited information available | euromed.es | 1971 | Nov 2018 | •••• | ||
Pharmaceutical distribution services are provided by Strathmann in Germany. | strathmann.de | Hamburg, Germany | 1974 | Jan 2018 | •••• | |
Diversified pharmaceutical drugs are manufactured by Trommsdorff in Germany. | trommsdorff.de | Alsdorf, Germany | 1797 | Jan 2018 | •••• | |
OTC drugs are manufactured by Axicorp in Germany. | axicorp.de | Friedrichsdorf, Germany | 2002 | Jun 2012 | •••• | |
R&D company focused on manufacturing generic drugs for multiple therapeutic areas | farmal.hr | Varazdin, Croatia | 1959 | Feb 2011 | $30.24M |
Complete acquisition details for Dermapharm
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Dermapharm
12 dated milestones of Dermapharm across 32 years, from founding to its latest funding, stage changes and deals.
- Founded Dermapharm is founded.
- Acquisition Acquires Farmal.
- Acquisition Acquires Axicorp.
- Acquisition Acquires Trommsdorff.
- Acquisition Acquires Strathmann.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Euromed.
- Acquisition Acquires Euromedgroup.
- Acquisition Acquires fitvia.
- Acquisition Acquires AllergoPharma.
- Acquisition Acquires C3 Cannabinoid Compound.
- Acquisition Acquires Arkopharma.
Web traffic of Dermapharm
The website of Dermapharm (dermapharm.de) receives about 2.3K visits a month and ranks #6,287,924 among all websites worldwide, #6,513 in Biotechnology and Pharmaceuticals.
- Monthly visits2.3K
▼ 8.7% vs previous month
- Unique visitors1.1K
per month
- Global rank#6,287,924
among all websites
- Category rank#6,513
Health · Biotechnology and Pharmaceuticals
- Bounce rate41%
- Pages per visit1.8
- Average visit45 sec
- DevicesDesktop 46% · Mobile 54%
Websites whose visitors overlap most with Dermapharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
arzneikompass.de | arzneikompass.de | 100% | #8,582,435 | – | |
| netdoktor.de | 61% | 2.4M | #32,858 | View details | |
leukaemie-hilfe.de | leukaemie-hilfe.de | 60% | #2,632,317 | – | |
multilind.de | multilind.de | 55% | #1,396,950 | – | |
allergie-elternmagazin.de | allergie-elternmagazin.de | 54% | #5,718,731 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Dermapharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dermapharm
Complete news archive for Dermapharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dermapharm
Dermapharm was founded in 1991.
Dermapharm is headquartered in Grunwald, Germany. It is registered at Grunwald, Bavaria, Germany.
Wilhelm Beier is the CEO of Dermapharm, as recorded in our data.
Dermapharm has 3,600 employees.
Annual revenue of Dermapharm is $1.36B as on Dec 31, 2025.
Dermapharm was founded in 1991 and is headquartered in Grunwald, Germany. Operations center on the pharmaceutical sector, with development and production of medications for skin conditions, allergies, and related health issues. The product range encompasses topical dermatological treatments and vitamin supplements. Patient support resources and educational materials are offered to assist users. Focus remains on standard healthcare solutions within the industry.
Dermapharm offers Vitamin D Supplements and Herpes Treatment Device.
Yes, Dermapharm is publicly traded on XETR under the ticker symbol DMP.
Dermapharm has made 10 acquisitions, including AllergoPharma, Arkopharma, and Axicorp.
Dermapharm operates through Dermapharm Ag.